Dina Titova works in the field of Rheumatology. She went to Bashkir State Medical University. She received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow". Dina Titova has written publications. She has 2 publications published with PubMed. The lastest paper is: '[The clinical efficacy of the first Russian angiotensin-converting enzyme inhibitor methiopril in patients with heart failure].' She accepts Medicare payments and is listed with Medicare.gov.
NPI NUMBER | 1861549651 | |
NPPES Provider LastName | TITOVA | |
NPPES Provider FirstName | DINA | |
NPPES Provider ZIPCode | 984993071 | |
NPPES Provider State | WA | |
Specialty Description | Rheumatology | |
Total Claim Count | 2960.0 | |
Distinct Opioid Count | 4.0 | |
Opioid Claim Count | 273.0 | |
Percent Opioid Claims | 9.22 |
National Provider Identifier [NPI] | 1861549651 |
Last Name Of The Provider | TITOVA |
First Name Of The Provider | DINA |
View All |
![]() |
Dr. Richard I. Rynes, MD
![]() |
![]() |
Dr. Zhiqian Roger Wang, MD
![]() |
![]() |
Dr. Mark W. Layton, MD |